ACTRN12616001052426已完成不适用
A proof-of-concept study to investigate the effect of ingestion of the probiotic PCC(Registered Trademark) (L. fermentum VRI-003) or placebo capsules on gut health when given to healthy adults (with no medically diagnosed gastrointestinal disease)
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Subject is in general good health with NO history of medically diagnosed gastrointestinal disease.
排除标准
- •Any medically diagnosed gastrointestinal disorder/disease (including inflammatory bowel disease, medically diagnosed IBS)
- •Clinically significant renal, hepatic, endocrine, cardiac, pulmonary, pancreatic, neurologic, haematologic or biliary disorder
研究者
相似试验
进行中（未招募）
1 期
A Proof of concept study to investigate the effect of the antiviral medication Telbivudine in patients with inflammatory heart muscle disease caused by the ParvovirusParvovirus B19-induced inflammatory cardiomyopathyEUCTR2016-004825-17-DECharité Universitätsmedizin Berlin25
进行中（未招募）
1 期
A proof-of-concept study to assess the effect of ACT-451840 against early Plasmodium falciparum blood stage infection in healthy subjects.Infection - Other infectious diseasesMalariaACTRN12614000781640James McCarthy8
已完成
不适用
A proof of concept study to evaluate the impact of a food supplement on uptake and anti-inflammatory properties of omega-3 fatty acid derived specialized pro-resolution lipid mediatorsHealthy volunteersDRKS00023304Evonik Operations GmbH19
已完成
不适用
A proof of concept study to evaluate the impact of a food supplement on production of short chain fatty acids and microbiome in healthy subjectshealthy volunteersDRKS00023166Evonik Operations GmbH18
已完成
不适用
Add-on salmeterol versus montelukast in Arg/Arg-16 asthmaticsAsthmaISRCTN49849003niversity of Dundee (UK)120